Investor Presentaiton

Camlin Fine Sciences ("CFS") | A quick introduction Company Overview CFS is a global player in shelf-life solution chemistry Summary financials (INR mn) FY14 FY15 FY16 ■ One of the leading manufacturers of TBHQ and BHA Net Sales 5,087 5,583 4,893 Global reach through manufacturing plants across India, Europe, Latin America with customers across key markets EBITDA 713 925 961 EBITDA% 13.8% 16.2% 19.1% ☐ Marquee client base; end-uses across Food, Pet food, Animal feed, Vanillin and Performance Chem. Vertically integrated company in the chemistry it operates in manufacturers (including contract manufacturing) entire chain of antioxidants, blends, Vanillin and Performance Chemicals derived from PAT 287 550 358 - PAT% 5.6% 9.6% 7.1% Phenol Net Worth 933 1,349 1,762 The company was demerged from Camlin Limited (erstwhile group company) and listed on Indian exchanges in 2006 Net Debt² 1,341 1,407 1,4833 Share price performance - CFS¹ Shareholding (as at March 31, 2016) 130 120 110 100 90 80 70 60 50 Jan-15 May-15 Sep-15 Jan-16 May-16 55.7% 4.5% 39.8% Other details Credit Rating ■ Promoters ■Insti Investors ■ Others Fitch: LT - Ind A; ST - Ind A1 Bankers to the IDBI Bank, Bank of India, OBC, Company Auditors SBI, SBT, EXIM Bank, SBP M/s. B.K. Khare & Co. Exchanges listed BSE ONSE EXPERIENCE THE NEW 1 Data from BSE Ltd. as on May 22, 2016 2 Net Debt for FY14 and FY15 includes current portion of LT Debt During the FY16 there is a charge for INR45.47mn due to short receipt of insurance claim relating to a fire which occurred during FY14 EBITDA includes other Income. Margins are calculated on gross basis SBT State Bank of Travancore; SBI - State Bank of India; SBP - State Bank of Patiala; OBC - Oriental Bank of Commerce 24 Market Cap¹ INR 9,100mn 52 wk. high/low¹1 INR 128.8/ INR 76.1 CFS Camlin Fine Sciences

View entire presentation